CIBC Private Wealth Group
GMAB icon

CIBC Private Wealth Group’s Genmab GMAB Stock Holding History

CIBC Private Wealth Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$25.5K Buy
827
+616
+292% +$19.2K ﹤0.01% 2078
2025
Q3 		$6.47K Sell
211
-572
-73% -$13.9K ﹤0.01% 2512
2025
Q2 		$16.2K Sell
783
-878
-53% -$18K ﹤0.01% 2097
2025
Q1 		$29.9K Sell
1,661
-70
-4% -$1.47K ﹤0.01% 1830
2024
Q4 		$38.4K Sell
1,731
-1,614
-48% -$35.5K ﹤0.01% 1782
2024
Q3 		$81.6K Buy
3,345
+13
+0.4% +$348 ﹤0.01% 1578
2024
Q2 		$84.9K Buy
3,332
+11
+0.3% +$312 ﹤0.01% 1462
2024
Q1 		$101K Buy
+3,321
New +$97.6K ﹤0.01% 1398
2023
Q4 		– Sell
-6,021
Closed -$212K – 1161
2023
Q3 		$212K Buy
+6,021
New +$229K ﹤0.01% 985
2022
Q3 		– Sell
-3,120
Closed -$101K – 1018
2022
Q2 		$101K Hold
3,120
– – ﹤0.01% 926
2022
Q1 		$113K Buy
+3,120
New +$107K ﹤0.01% 995

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CIBC Private Wealth Group's GMAB Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Genmab (GMAB) stake by 292% in Q4 2025, buying an estimated $19.2K and bringing the position to 827 shares worth $25.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2078.

CIBC Private Wealth Group first reported a position in GMAB in Q1 2022 and has held it in 11 quarters since. The position peaked at $212K in Q3 2023. 292 funds tracked by Wall St. Rank hold GMAB as of Q4 2025.

  • CIBC Private Wealth Group held 827 shares of Genmab worth $25.5K as of Q4 2025.
  • CIBC Private Wealth Group bought 616 Genmab shares in Q4 2025, an estimated $19.2K.
  • Genmab made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2078 holding.
  • CIBC Private Wealth Group first reported a position in Genmab in Q1 2022 and has held it in 11 quarters since.
  • CIBC Private Wealth Group's Genmab position peaked at $212K in Q3 2023.
  • 292 funds tracked by Wall St. Rank held Genmab as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.